FindTrial
Sign In

Expression of TLR2/TLR4 in T Cell Subsets of Parkinson's Disease Patients and Its Clinical Correlation

Expression of TLR2/TLR4 in T Cell Subsets of Parkinson's Disease Patients and Its Clinical significance

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085917
Enrollment
Unknown
Registered
2024-06-21
Start date
2024-06-23
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

parkinson‘s disease

Interventions

parkinson's group:NA
control group:NA

Sponsors

shenzhen baoan people's hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: parkinson‘s disease

Exclusion criteria

Exclusion criteria: Undergoing deep brain stimulation and other neurosurgical procedures Having a history of diabetes or autonomic neuropathy at the initial assessment; Having a history of symptomatic stroke that may affect general cognition or performance; Having a history of heart failure or an electrocardiogram showing atrial fibrillation; Currently using medications known to affect the central dopaminergic, noradrenergic, and/or serotonergic systems at the time of diagnosis.

Design outcomes

Primary

MeasureTime frame
TLR4 TLR2 Expression on T Cells;—

Countries

China

Contacts

Public ContactYifan Zhang

shenzhen baoan people's hospital

yifanhahahah@163.com+86 139 2849 1802

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026